New Clot-Busting device could ease Long-Term leg pain
NCT ID NCT07622212
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study compares two medical devices used to remove large blood clots from the leg veins. About 180 adults with acute deep vein thrombosis (DVT) will receive either the ClotTriever System or an aspiration device. The goal is to see which device clears clots better and reduces the risk of post-thrombotic syndrome, a condition causing chronic leg pain and swelling.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ClotTriever System and aspiration thrombectomy devices
- What this could lead to
- If successful, this could identify a better device for removing blood clots in the leg, potentially reducing long-term complications like pain and swelling.
- What could go wrong
- This is a relatively small, early-stage comparison study. Results may not apply to all patients, and both procedures carry risks like bleeding or vessel damage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DEEP VEIN THROMBOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Renji hospital
RECRUITINGShanghai, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simple 5-Step nursing plan could slash deadly clot risk after hip surgery
- Timing of blood thinners after childbirth bleeding may prevent clots without causing more harm
- New fingerstick test for blood thinner monitoring put to the test
- New Finger-Prick test could speed up blood clot diagnosis
- Hidden vein clot cleanup may prevent chronic leg pain
- Big data vs. clinical trials: can insurance records match gold-standard results?